SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare informs about outcome of postal ballot

28 Apr 2025 Evaluate
Further to letter dated March 27, 2025 enclosing a copy of the Postal Ballot notice seeking approval of the members for the resolutions stated therein, Remedium Lifecare has informed that pursuant to section 110 of the Companies Act, 2013 read with rule 20 and 22 of the Companies (Management and Administration) Rules 2014, the Company has conducted Postal Ballot process vide its Postal Ballot Notice dated March 27, 2025 for seeking assent/dissent to the resolutions provided in the Postal Ballot Notice. The Board has appointed Mehul Pitroda, proprietor at M S Pitroda & Co, (ACS No. 43364, CP No. 20308), Practicing Company Secretaries, to act as Scrutinizer for the Postal Ballot process. The Voting on Postal Ballot commenced Friday, March 28, 2025 at 09:00 am (IST) and ended on Saturday, April 26, 2025 at 05:00 pm (IST) The postal ballots (e-voting) were duly Scrutinized by the Scrutinizer and the report submitted thereon on April 28, 2025. Pursuant to Regulation 44 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, they reproduce the e-voting postal ballot Notice dated March 27, 2024. All the resolutions set out in the notice of postal ballot were duly passed by requisite majority. Enclosed the result pdf the Postal Ballot along with Scrutinizer's Report dated April 28, 2025. The following Items of Business as laid down in the Postal Ballot Notice dated March 27, 2025: Appointment of Shamim Adil Michal (DIN: 10913814) as an Independent Director. The date of declaration of result is April 28, 2025. 

The above information is a part of company’s filings submitted to BSE.



Supha Pharmachem Share Price

0.29 -0.01 (-3.33%)
11-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 231.05
Amrapali Industries 33.42
Adani Enterprises 2908.15
Rashi Peripheral 529.75
PDS 299.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: